|
In highly competitive markets, companies can often gain ground in their competitive position by building new social dimensions into their product and service offerings. One of the newest frontiers for competitive advantage is leveraging the core resources and skills of the company to achieve societal benefit.
FSG can lead you through an analysis of your core strengths, use a research-driven process to match them to social needs, and design initiatives that can be the basis for your sustainable competitive positioning going forward.
Challenge
- Identify areas where the needs for antimalarial drug are not being met
- Determine whether to invest in further development of new combination therapy
- Pinpoint target indications where product could make a significant impact on the disease
Approach
- Researched current indications of prevailing antimalarial drugs and studies on their efficacy, safety, etc.
- Determined that infant mortality rate in Africa was worst outcome of Malaria
- Interviewed more than 40 global experts to identify the specific target profile for the new antimalarial drug
- Tested several product profile opportunities with stakeholders
- Reviewed results with a cross-functional team including marketing, R&D, and philanthropy
Results
- Determined that treatment and prevention for infants and pregnant women present greatest unmet need for antimalarial drugs
- Pfizer solidified investment and public commitment to development of antimalarial therapies for infants and pregnant women
Visit Pfizer's malaria initiative Web site » |
